Ponatinib leukemia drug

Ponatinib leukemia drug

F007/0177 Royalty Free

Request un-watermarked file

Price image Pricing

Please login to use the price calculator


Credit: MOLEKUUL/SCIENCE PHOTO LIBRARY

Caption: Ponatinib leukemia drug, molecular model. Ponatinib is approved for the treatment of chronic myelogenous leukemia. Atoms are represented as spheres and are colour-coded: hydrogen (white), carbon (grey), oxygen (red), fluorine (dark yellow) and nitrogen (blue).

Release details: Model release not required. Property release not required.

Keywords: acute lymphoblastic leukaemia, all, ap24534, artwork, atom, ball and stick, bcr-abl, biochemistry, cancer, chemical, chemical element, chemistry, chronic myelogenous leukemia, cml, drug, gleevec, healthcare, iclusig, imatinib, leukaemia drug, medical, medical illustration, medicine, model, molecular model, molecular structure, molecule, myelogenous leukaemia, pharmacology, philadelphia chromosome, ponatinib, sphere, structure, therapeutic, tyrosine-kinase inhibitor, white background

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.